Switzerland 3D Imaging Market Analysis Report 2022 to 2030

Switzerland 3D Imaging Market Analysis

$ 3999

Switzerland's 3D imaging market is projected to grow from $xx Bn in 2022 to $xx Bn by 2030, registering a CAGR of xx% during the forecast period of 2022-30. The market will be driven by increasing demand for advanced medical imaging technologies and the growing prevalence of chronic diseases. The market is segmented by product, application, by end-user & by portability. Some of the major players include GE Healthcare, Philips Healthcare, Hitachi Healthcare, etc.

ID: IN10CHDH001 CATEGORY: Digital Health GEOGRAPHY: Switzerland AUTHOR: Vidhi Upadhyay

Buy Now

Switzerland 3D Imaging Market Executive Summary

Switzerland's 3D imaging market is projected to grow from $xx Bn in 2022 to $xx Bn by 2030, registering a CAGR of xx% during the forecast period of 2022-30. According to the World Health Organization Global Health Expenditure database, Switzerland's health expenditure (% of GDP) fell from 11.38% in 2018 to 11.29% in 2019 as a result of the pandemic. It is anticipated to rise by another 15% by 2050. Switzerland ranks 3^rd in LPI 2020 ranking and 18^th in CEO World ranking in terms of best healthcare. Around 42 000 new cancer diagnoses are recorded in 2021, including 26 000 in males and 22 000 in women in the country. The primary cause of this rise is demographic change, with a rising number of elderly persons.

Over the last several years, the usage of 3D Imaging has rapidly increased in Switzerland, with numerous medical facilities embracing the technology for a range of purposes. One application of 3D Imaging that has experienced tremendous progress in Switzerland is surgical planning. Surgeons may generate precise models of a patient's anatomy using 3D imaging, allowing them to plan and prepare for surgical treatments with higher precision and accuracy. 3D Imaging technology is widely used in the diagnosis and treatment of a variety of chronic illnesses, including cancer, cardiovascular illness, and neurological disorders, in addition to surgical planning.

Market Dynamics

Market Growth Drivers

In August 2022, The CERN hosted the sixth Workshop on Medical Applications of Spectroscopic X-ray Detectors. The workshop is attended by about 100 people, including doctors, radiologists, medical physicists, biologists, tracer developers, imaging system professionals, and detector and ASIC developers. Such intersections of research and innovation with businesses are major drivers for the market. One of the other drivers is the increasing prevalence of chronic diseases such as cancer and cardiovascular disease & growing need for minimally invasive surgical treatments. Furthermore, the rise of focused therapy and personalized healthcare, as well as the increased use of advanced visualization software technologies, are driving the 3D Imaging mark in Switzerland. These factors are expected to propel market development in the coming years.

Market Restraints

One of the primary commercial constraints is the high cost of advanced imaging technologies. While these technologies are critical for illness diagnosis and treatment, they can be too expensive for some individuals and healthcare providers. Despite the fact that the country has a well-developed medical device regulatory framework, the licensing process can be time-consuming and difficult. This makes it difficult for smaller companies with fewer resources to bring breakthrough imaging technologies to market, and it has the potential to impede industry innovation.

Competitive Landscape

Key Players

GE Healthcare
Siemens Healthineers
Philips Healthcare
Canon Medical Systems
Fujifilm Holdings Corporation
Hitachi Healthcare
Sectra AB

Notable Deals

November 2022, Philips enhanced AI-powered diagnostic technologies and transformational workflow solutions at RSNA 2022
In October 2022, Philips revealed two significant advancements in MR-only procedures for head and neck cancer radiation imaging and simulation
In September 2022, GE Healthcare’s deep-learning 3D Imaging system received an FDA expanded approval. Also, it’s “AIR Recon DL” Received FDA Approval for 3D and Motion-Insensitive Imaging Applications for Superior Image Quality and Patient Experience in MRI

Healthcare Policies and Regulatory Landscape

The Federal Office of Public Health (FOPH) monitors public health, determines Swiss health policy, and ensures that the country's healthcare system is efficient and inexpensive. Switzerland adopts the European Union (EU) method of conformity evaluation and certification for medical devices, which is based on bilateral agreements. Private businesses assess compliance with globally recognized rules.

Reimbursement Scenario

Despite the fact that Switzerland's healthcare system is universal, there is no free public healthcare in the country. Instead, all Swiss citizens must pay for their own private health insurance.

1. Executive Summary
1.1 Digital Health Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Digital Health Policy in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Switzerland 3D Imaging Market Segmentation

By Product (Revenue, USD Billion):

The 3D Imaging Market is divided majorly into X-ray Imaging Systems, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Ultrasound & Nuclear Imaging Systems. X-ray Imaging systems have the highest market share in the 3D Imaging market. 3D X- rays are mostly utilized for dental and orthopedic applications. 3D Ultrasound is majorly helpful in tracking the dynamic motion of arteries, and veins and also has applications for various fetal, cardiac, obstetric, and rectal examinations, and many more. The ultrasound segment is predicted to develop substantially over the forecast period, primarily to the advancements in technology in the healthcare industry and the several advantages given by 3D ultrasound imaging over standard ultrasound imaging.

X-ray Imaging Systems
Computed Tomography (CT)
Magnetic Resonance Imaging (MRI)
Ultrasound
Nuclear Imaging systems

By Application (Revenue, USD Billion):

The market for 3D Imaging has applications covering Cardiology, Neurology, Orthopaedics, Gynaecology, Oncology, and other areas of diagnostics as well. Cardiovascular diseases are the leading cause of death globally. The second biggest cause is cancers because of which Oncology holds the highest market share in the 3D Imaging market followed by cardiology as 3D imaging is highly utilized in these two segments for diagnostics and treatments of the same. Neurosurgeons desire three-dimensional (3D) imagery of intracranial tumors, neural structures, skulls, and veins to establish a clear visual image of the surgical field's anatomical orientation prior to surgical intervention aiding better surgical outcomes for patients. Obstetricians employ 3D ultrasound scans to see the gestational sac, pinpoint the location of an ectopic pregnancy, and evaluate for fetal deformities of the face, spine, limbs, and heart. 3D Imaging applications for gynecology are yet in evolving stage and have a great scope for expansion allowing feasible and quick patient care.

Cardiology
Neurology
Orthopedics
Gynecology
Oncology
Others (Urology, etc.)

By End User (Revenue, USD Billion):

Hospitals, Diagnostic Imaging Centers, and other end-user such as private clinics make up the segments of the 3D Imaging Market. The hospitals among these hold the biggest market share due to the increased uptake of cutting-edge medical technology, the expansion of existing 3D Imaging facilities, the rising affordability of 3D Imaging services, the rising prevalence of chronic conditions such as cardiovascular diseases, cancers, respiratory diseases which lead to rising in demand for precise and quick diagnostic and treatment options. Diagnostic Imaging Centers have also been deploying 3D Imaging equipment to improve their standard of care.

Hospitals
Diagnostic Imaging Centers
Other End Users

By Portability (Revenue, USD Billion):

The 3D Imaging market is divided into two segments Stationary & Mobile, considering the portability of the device. Stationary 3D imaging involves equipment that is installed at a particular location and is operated from the same location of installment whereas mobile ones can be relatively smaller in size and hence moved to the patients who are unable to locate the Imaging room. Mobile MRI, Ultrasound, X–ray & CT allow cutting-edge healthcare to be delivered to nearly any location and are yet in the developing stages of expansion.

Stationary
Mobile

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.